Echo Street Capital Management LLC Novavax Inc Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $255,437 - $1.07 Million	14,035 New	14,035 $255,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $461,916 - $958,592	-12,732 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $495,152 - $1.01 Million	7,101 Added 126.11%	12,732 $938,000
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $404,487 - $655,217	3,006 Added 114.51%	5,631 $806,000
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $541,756 - $824,457	-3,047 Reduced 53.72%	2,625 $544,000
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $434,390 - $925,035	3,590 Added 172.43%	5,672 $1.2 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $235,224 - $666,094	2,082 New	2,082 $377,000

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.